Traditional Chinese medicine composition for treating hyperplasia of prostate gland and application thereof

Abstract

The invention discloses a traditional Chinese medicine composition for treating hyperplasia of prostate gland. The traditional Chinese medicine composition comprises an internal component and an external component; the internal component comprises the following raw materials by weight: 12-18 parts of prepared common monkshood daughter roots, 14-6 parts of astragalus roots, 24-36 parts of cinnamonbark, 8-10 parts of cassia twigs, 12-18 parts of dodder, 12-18 parts of epimedium, 24-36 parts of raw ginger, 10-14 parts of Chinese angelica roots, 4-6 parts of dried leech, 10-14 parts of achyranthes roots, 3-5 parts of pangolin scales, 10-14 parts of zedoary turmeric rhizomes, 12-18 parts of poria cocos, and 12-18 parts of bighead atractylodes rhizomes; the external component includes: 4-6 parts of phellodendron bark, 4-6 parts of plantain seeds, 4-6 parts of oriental water plantain rhizomes, 4-6 parts of hedyotis, 4-6 parts of seeds of cowherb, 4-6 of herb of christina losesetrife, 2.5-3.5of parts of rhubarb roots, 2.5-3.5 parts of earthworm, 1.5-2.5 parts of myrrh, and 1.5-2.5 parts of frankincense. The traditional Chinese medicine composition adopts internal and external treatment,and has remarkable curative effect and wide application prospects.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine compositions, more specifically, to a traditional Chinese medicine composition for treating benign prostatic hyperplasia and its application. Background technique [0002] Prostatic hyperplasia, which is called prostatic hyperplasia in traditional Chinese medicine, is a common disease and a high incidence of men, especially men of advanced age (referring to men over 60 years old). Common clinical symptoms of benign prostatic hyperplasia are: frequent urination, urgency, urinary weakness, waiting to urinate, dribbling, urinary obstruction, urethral pain, urinary retention, and overflow incontinence. According to statistics, the incidence rate of benign prostatic hyperplasia is greater than 50% at the age of 60, and it is as high as 83% at the age of 80. With the arrival of my country's aging society, the number of patients with benign prostatic hyperplasia will increase. [0003] In re...

AI Technical Summary

Problems solved by technology

However, whether to treat the "symptoms" or the "roots" mainly, different choices will directly affect the curative effect, but this degree is difficult to grasp

In addition, most of the "basic" drugs are warm products, while most of the "standard" drugs are cold products. It is difficult to avoid mutual involvement between cold and hot drugs in the same prescription. This involvement will ultimately affect the therapeutic effect. to uncertainty

Images